“‘SALIVARY INTERLEUKIN-6 AS A BIOMARKER OF COVID-19 SEVERITY’”, Aca. Glo. Ind.Res., vol. 4, no. 02, pp. 45–52, Feb. 2023, doi: 10.17605/OSF.IO/24H87.